While the exact cause of SLE is unknown, it is believed to involve a combination of genetic, hormonal, and environmental factors, with individuals assigned female at birth and those of African American, American Indian, and Asian descent being at higher risk
Our findings highlight the need to develop supplements or interventions to lower palmitoyl-L-carnitine synthesis or levels as a promising treatment approach
This short phase IIa IMODALS trial, as a prelude to the phase IIb/III MIROCALS trial, showed that low-dose IL-2 (aldesleukin) produces a robust upregulation of the peripheral T reg cell count and a lowering of at least one inflammatory mediator (MCP-1/CCL2)
MATERIAL Y MTODOS Se realiz un estudio de reporte de casos, analtico y longitudinal, durante tres meses, en el rea de hemodilisis peditrica de la unidad mdica de alta especialidad de Gineco/Pediatra del IMSS, nmero 48, de la ciudad de Len, Gto